Company profile
Marijuana Inc.
OTC: MAJI · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ 14GM —SS 30
v0.1 · 25/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ workforce scale, return on assets
Methodology →Revenue TTM
$500
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$435.9k
Employees
1
as of 2026-08-27
Market cap
$330.4k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02020
Net income-$435.9k-$435.9k2020
Operating income-$467.9k-$467.9k2020
Total assets$58.3k$58.3k2020
Liabilities$444.8k$444.8k2020
Equity-$386.5k-$386.5k2020
Revenue trend
FY2012 – FY2020 · USD
FY12
FY12
FY19
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Marijuana Inc.’s revenue?
Marijuana Inc. booked $0 in FY2020 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Alternative Energy Partners, Inc.——Actavia Life Sciences, Inc.——Biocure Technology Inc.——Bakhu Holdings, Corp.——Planet Based Foods Global Inc.37DBio-Path Holdings, Inc.——Neighbors
Lee →Key facts
CEODonald J. Steinberg
SectorHealthcare
IndustryBiotechnology
HeadquartersEstero, FL
ExchangeOTC: MAJI
Employees1
IPO date2012-02-09
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.